Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation

被引：36

作者：

Krause, K. ^{[1
]}

Gimenez-Arnau, A. ^{[2
]}

Martinez-Escala, E. ^{[2
]}

Farre-Albadalejo, M. ^{[2
]}

Abajian, M. ^{[1
]}

Church, M. K. ^{[1
]}

Maurer, M. ^{[1
]}

机构：

[1] Charite, Allergie Ctr Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany

[2] Univ Autonoma Barcelona, Dept Dermatol & Pharmacol, Hosp del Mar, E-08193 Barcelona, Spain

来源：

ALLERGY | 2013年 / 68卷 / 02期

关键词：

histamine; microdialysis; platelet-activating factor; prostaglandin D2; wheal and flare; IN-VIVO; HISTAMINE; RESPONSES; RELEASE; ANTIHISTAMINES; MICRODIALYSIS; BRADYKININ; CETIRIZINE; URTICARIA;

D O I：

10.1111/all.12083

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Background Platelet-activating factor (PAF) causes wheal and flare responses which are abrogated by H1-antihistamines giving rise to the hypothesis that PAF-induced wheal development is secondary to histamine release from dermal mast cells. But is this hypothesis correct? Methods Wheal and flare responses were induced by intradermal injection of PAF, codeine and histamine in 14 healthy volunteers. Dermal histamine and PGD2 contractions were measured using microdialysis. Results PAF, unlike histamine and codeine, did not cause a statistically significant rise in mean histamine levels with ten persons showing negligible histamine release. Codeine caused a significant but variable histamine release, ranging from 29 to 282 ng/ml. Codeine, but not PAF or histamine, caused a small but statistically significant release of PGD2. Conclusion Wheal and flare reactions in human skin induced by PAF are not associated with histamine release and, therefore, appear to be independent of mast cell degranulation.

引用

页码：256 / 258

页数：3

共 15 条

[1] INFLAMMATORY CHARACTERISTICS OF PLATELET ACTIVATING FACTOR (PAF-ACETHER) IN HUMAN-SKIN [J].

ARCHER, CB ;

PAGE, CP ;

PAUL, W ;

MORLEY, J ;

MACDONALD, DM .

BRITISH JOURNAL OF DERMATOLOGY, 1984, 110 (01) :45-50

[2] DIFFERENTIAL RELEASE OF HISTAMINE AND EICOSANOIDS FROM HUMAN-SKIN MAST-CELLS ACTIVATED BY IGE-DEPENDENT AND NON-IMMUNOLOGICAL STIMULI [J].

BENYON, RC ;

ROBINSON, C ;

CHURCH, MK .

BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (03) :898-904

[3] Class A GPCR heterodimers: evidence from binding studies [J].

Birdsall, Nigel J. M. .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (11) :499-508

[4] Opioid-induced mast cell activation and vascular responses is not mediated by μ-opioid receptors:: An in vivo microdialysis study in human skin [J].

Blunk, JA ;

Schmelz, M ;

Zeck, S ;

Skov, P ;

Likar, R ;

Koppert, W .

ANESTHESIA AND ANALGESIA, 2004, 98 (02) :364-370

[5] The histamine H1-receptor antagonist cetirizine does not interact with bradykinin B1 or B2-receptors in vitro [J].

Christophe, B ;

Maleux, MR ;

Gillard, M ;

Chatelain, P ;

Peck, MJ ;

Massingham, R .

INFLAMMATION RESEARCH, 2004, 53 (Suppl 1) :S81-S82

[6] Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males [J].

Church, M. K. .

BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (06) :1330-1332

[7] What can microdialysis tell us about the temporal and spatial generation of cytokines in allergen-induced responses in human skin in vivo? [J].

Clough, Geraldine F. ;

Jackson, Claire L. ;

Lee, Jacob J. P. ;

Jamal, Sarah C. ;

Church, Martin K. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (12) :2799-2806

[8]

Clough GF, 1998, BRIT J DERMATOL, V138, P806

[9] ASSOCIATION OF PLATELET-ACTIVATING FACTOR WITH PRIMARY ACQUIRED COLD URTICARIA [J].

GRANDEL, KE ;

FARR, RS ;

WANDERER, AA ;

EISENSTADT, TC ;

WASSERMAN, SI .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (07) :405-409

[10]

JUHLIN L, 1992, ACTA DERM-VENEREOL, V72, P197

← 1 2 →